For: | Tuna N, Karabay O. Hepatitis B reactivation and timing for prophylaxis. World J Gastroenterol 2015; 21(7): 2263-2264 [PMID: PMC4326171 DOI: 10.3748/wjg.v21.i7.2263] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i7/2263.htm |
Number | Citing Articles |
1 |
Fernando Bessone, Melisa Dirchwolf. Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations. World Journal of Hepatology 2016; 8(8): 385-394 doi: 10.4254/wjh.v8.i8.385
|
2 |
Hasan Tahsin Gozdas, Erkan Arpaci. Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin’s lymphoma. World Journal of Gastroenterology 2015; 21(35): 10251-10252 doi: 10.3748/wjg.v21.i35.10251
Abstract(1077) |
Core Tip(1149) |
Full Article(HTML)(2480)
|
Full Article (PDF)-546K(307)
|
Full Article (Word)-75K(166)
|
Peer-Review Report-82K(196)
|
Answering Reviewers-102K(176)
|
Times Cited (0)
|
Total Visits (8877)
|
Open
|
3 |
Mohit Mittal, Ke-Qin Hu. Clinical Implications and Management of Chronic Occult Hepatitis B Virus Infection. Current Hepatology Reports 2017; 16(2): 90 doi: 10.1007/s11901-017-0339-9
|